FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1459292019 Transdermal patch (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479376011 Transdermal patch en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479376011 Transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2621574015 Patch en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2621574015 Patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2660372013 Transdermal patch (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660372013 Transdermal patch (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
37211000188110 dispositif cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
37211000188110 dispositif cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Has dose form intended site (attribute) Transdermal (intended site) true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Is a Transdermal dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Has dose form administration method (attribute) Apply true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Has dose form transformation (attribute) No transformation true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier (core metadata concept)
Prolonged-release transdermal patch Has basic dose form (attribute) Patch true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Capsaicin 179mg/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Buprenorphine 5microgram/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 11mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 22mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Glyceryl trinitrate 400 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.025mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.0375mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.05mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.075mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.1mg/day patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Scopolamine 0.5mg/24 hr patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 14mcg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Selegiline 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Selegiline 9mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Selegiline 12mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rivastigmine 4.6mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rivastigmine 9.5mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 0.06mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 3.125 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 1.042 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 1.563 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 2.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Fentanyl 25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely testosterone 104.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Buprenorphine 52.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Fentanyl 75 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 208.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Testosterone 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 291.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 312.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 583.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glyceryl trinitrate 625 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rotigotine 250 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 875 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 1.04 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 1.56 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 583 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely selegiline 500 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Oxybutynin 162 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely selegiline 375 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 458 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rivastigmine 192 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rotigotine 125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Buprenorphine 5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Nicotine 1.563 mg/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start